The DOI matches its Crossref record; 140 of the 146 references it cites were found in a registry or an index.
Why Is Androgen Replacement in Males Controversial?
Abstract
Context: Symptoms and signs consistent with androgen deficiency and low testosterone levels are recognized frequently in clinical practice. Recent population-based epidemiological studies indicate that low testosterone levels in men are associated with increased morbidity and mortality. The clinician must be able to counsel patients to help them determine whether testosterone replacement therapy is appropriate for them. Evidence Acquisition: The authors have conducted a literature search in PubMed, and we have reviewed references in the multiple systematic reviews and meta-analyses that have been published on this topic. Evidence Synthesis: We have attempted to provide the reader with an appreciation of the evidence that can be used to support the diagnosis of androgen deficiency, the efficacy of treatment, the potential risks of treatment, the therapeutic options, and the recommendations for monitoring treatment. Conclusions: We think that published clinical experience justifies testosterone replacement therapy in males who have not initiated puberty by age 14 and in males with low testosterone levels due to classical diseases of the hypothalamic-pituitary-gonadal axis. The benefit:risk ratio is less certain in older men and in those with chronic diseases associated with low testosterone levels. The decision to treat in this setting is much more controversial because there are few large clinical trials that have demonstrated efficacy and no large clinical trials that have determined potential risks of increasing the incidence of clinical prostate cancers or cardiovascular events. We provide a critical review of the evidence that supports treatment and potential risks and ways to reduce the risks if the physician and patient elect testosterone replacement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a verdict can only be reached with large-scale studies including 5000 men over 5 years (95)”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [95]
In the citing paper
“It is still hotly debated whether this is a true form of hypogonadism, or a decline of serum testosterone associated with the progressive accumulation of health problems with aging (95, 96), but rather independently of the process of aging itself.”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [95]
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Heart Disease and Stroke Statistics—2009 Update
WRITING GROUP MEMBERS, Lloyd‐Jones, D. M., Adams, R. J., Carnethon, M. R., SIMONE, G. D., Ferguson, T. B., Flegal, K. M., Ford, E. S., Furie, K. L., Go, A. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191259 · Cited by 3,915
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191261 · Cited by 3,140
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
The Development of Human Benign Prostatic Hyperplasia with Age
Berry, S. J., Coffey, D. S., Walsh, P. C., & EWING, L. L. (1984) · The Journal of Urology · doi:10.1016/s0022-5347(17)49698-4 · Cited by 2,491
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Self-citationFeldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Identification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Cited by
Sorted by citations
Camacho, E. M., Huhtaniemi, I. T., O'Neill, T. W., Finn, J. D., Pye, S. R., Lee, D. M., Tajar, A., Bartfai, G., Boonen, S., Casanueva, F. F., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0890 · Cited by 392
Low Testosterone in Men with Type 2 Diabetes: Significance and Treatment
Grossmann, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0118 · Cited by 350
Basaria, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61126-5 · Cited by 328
Buvat, J., Maggi, M., Guay, A. T., & Torres, L. O. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02783.x · Cited by 285
Onset of effects of testosterone treatment and time span until maximum effects are achieved
Saad, F., Aversa, A., Isidori, A. M., Zafalon, L., Zitzmann, M., & Gooren, L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0221 · Cited by 232
Late-onset hypogonadism: Current concepts and controversies of pathogenesis, diagnosis and treatment
Huhtaniemi, I. T. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122336 · Cited by 203
Late-Onset Hypogonadism and Mortality in Aging Men
Pye, S. R., Huhtaniemi, I. T., Finn, J. D., Lee, D. M., O’Neill, T. W., Tajar, A., Bártfai, G., Boonen, S., Casanueva, F. F., Forti, G., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2052 · Cited by 206
Yeap, B. B., Alfonso, H. S., Chubb, S. A. P., Handelsman, D. J., Hankey, G. J., Almeida, O. P., Golledge, J., Norman, P. E., & Flicker, L. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3272 · Cited by 188
Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels
Cunningham, G. R., Stephens-Shields, A. J., Rosen, R. C., Wang, C., Bhasin, S., Matsumoto, A. M., Parsons, J. K., Gill, T. M., Molitch, M. E., Farrar, J. T., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1645 · Cited by 162
Self-citationApproach to the patient with hypogonadotropic hypogonadism
Silveira, L. F. G., & Latronico, A. C. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3550 · Cited by 161
Yeap, B. B., Alfonso, H., Chubb, S. A. P., Handelsman, D. J., Hankey, G. J., Norman, P. E., & Flicker, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2265 · Cited by 155
Risks and benefits of testosterone therapy in older men
Spitzer, M., Huang, G., Basaria, S., Travison, T. G., & Bhasin, S. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.73 · Cited by 154
Scinicariello, F., & Buser, M. C. (2016) · Environmental Health Perspectives · doi:10.1289/ehp150 · Cited by 147
Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism
Bouvattier, C. M., Maione, L., Bouligand, J., Dodé, C., Guiochon‐Mantel, A., & Young, J. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.164 · Cited by 143
Strandberg, T. E., Pitkälä, K. H., & Tilvis, R. S. (2011) · European Geriatric Medicine · doi:10.1016/j.eurger.2011.08.003 · Cited by 134
Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline
Morales, Á., Bebb, R. A., Manjoo, P., Assimakopoulos, P., Axler, J., Collier, C. P., Elliott, S., Goldenberg, L., Gottesman, I. S., Grober, E. D., et al. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.150033 · Cited by 117
Approach to the Male Patient with Congenital Hypogonadotropic Hypogonadism
Young, J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1664 · Cited by 110
Testosterone and glucose metabolism in men: current concepts and controversies
Grossmann, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0393 · Cited by 104
Yeap, B. B., Alfonso, H. S., Chubb, S. A. P., Hankey, G. J., Handelsman, D. J., Golledge, J., Almeida, O. P., Flicker, L. A., & Norman, P. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2664 · Cited by 94
Hyde, Z., Flicker, L. A., McCaul, K. A., Almeida, O. P., Hankey, G. J., Chubb, S. A. P., & Yeap, B. B. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0129 · Cited by 93
Singh, P. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.123552 · Cited by 98
Male late-onset hypogonadism: pathogenesis, diagnosis and treatment
Huhtaniemi, I., & Forti, G. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.47 · Cited by 88
The Laboratory Diagnosis of Testosterone Deficiency
Paduch, D. A., Brannigan, R. E., Fuchs, E. F., Kim, E. D., Marmar, J. L., & Sandlow, J. I. (2014) · Urology · doi:10.1016/j.urology.2013.12.024 · Cited by 79
Cholesterol and male fertility: What about orphans and adopted?
Maqdasy, S., Baptissart, M., Vega, A., Baron, S., Lobaccaro, J. A., & Volle, D. H. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.011 · Cited by 78
Association of Testosterone Levels With Endothelial Function in Men
Empen, K., Lorbeer, R., Dörr, M., Haring, R., Nauck, M. A., Gläser, S., Krebs, A., Reffelmann, T., Ewert, R., Völzke, H., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.232876 · Cited by 64
Sinha, I., Sinha‐Hikim, A. P., Wagers, A. J., & Sinha‐Hikim, I. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1900-2 · Cited by 60
Actions of 17β-estradiol and testosterone in the mitochondria and their implications in aging
Vasconsuelo, A., Milanesi, L., & Boland, R. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.09.001 · Cited by 55
From mitochondria to sarcopenia: role of 17β-estradiol and testosterone
Tian, X., Lou, S., & Shi, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1156583 · Cited by 54
Do low testosterone levels contribute to ill-health during male ageing?
Yeap, B. B., de Araújo, A. B., & Wittert, G. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.725461 · Cited by 53
Tan, W. S., Low, W. Y., Ng, C. J., Tan, W. K., Tong, S. F., Ho, C. C. K., Khoo, E. M., Lee, G., Lee, B. C., Lee, V., et al. (2013) · British Journal of Urology · doi:10.1111/bju.12037 · Cited by 51
Male acquired hypogonadotropic hypogonadism: Diagnosis and treatment
Salenave, S., Trabado, S., Maione, L., Brailly‐Tabard, S., & Young, J. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.03.040 · Cited by 51
Cunningham, R. L., Singh, M., O’Bryant, S. E., Hall, J. R., & Barber, R. C. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131994 · Cited by 50
Hormonal changes and their impact on cognition and mental health of ageing men
Yeap, B. B. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.05.015 · Cited by 49
Konaka, H., Sugimoto, K., Orikasa, H., Iwamoto, T., Takamura, T., Takeda, Y., Shigehara, K., Iijima, M., Koh, E., Namiki, M., et al. (2015) · Asian Journal of Andrology · doi:10.4103/1008-682x.148720 · Cited by 45
Hypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review
Russo, V., Chen, R., & Armamento‐Villareal, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.607240 · Cited by 41
Caveat Emptor: Does Testosterone Treatment Reduce Mortality in Men?
Wu, F. C. W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1977 · Cited by 40
Pintana, H., Pongkan, W., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2015) · AGE · doi:10.1007/s11357-015-9827-4 · Cited by 39
Wang, Y., Shang, Y., Mishra, A., Bacon, E., Yin, F., & Brinton, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-65402-5 · Cited by 42
The Long and Tortuous History of the Discovery of Testosterone and Its Clinical Application
Morales, Á. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12081 · Cited by 35
Lau, C. G., Ho, J. Y. S., Hung, C. H.-L., Wuwongse, S., Poon, C.-H., Chiu, K., Yang, X., Chu, L., & Chang, R. C. (2014) · BioMed Research International · doi:10.1155/2014/103906 · Cited by 36
Testosterone deficiency, insulin-resistant obesity and cognitive function
Pintana, H., Chattipakorn, N., & Chattipakorn, S. C. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9655-3 · Cited by 33
Giagulli, V. A., Triggiani, V., Carbone, M. D., Corona, G., Tafaro, E., Licchelli, B., & Guastamacchia, E. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02497.x · Cited by 32
Kim, C., Cushman, M., Kleindorfer, D., Lisabeth, L. D., Redberg, R. F., & Safford, M. M. (2015) · Current Cardiology Reviews · doi:10.2174/1573403x1103150515110749 · Cited by 29
Yeap, B. B., Alfonso, H. S., Chubb, S. A. P., Handelsman, D. J., Hankey, G. J., Golledge, J., Flicker, L. A., & Norman, P. E. (2013) · Clinical Endocrinology · doi:10.1111/cen.12208 · Cited by 25
Hormones and health outcomes in aging men
Yeap, B. B. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.07.012 · Cited by 28
Featured paper Andropause – State of the art 2015 and review of selected aspects
Jakiel, G., Makara‐Studzińska, M., Ciebiera, M., & Słabuszewska-Jóźwiak, A. (2015) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2015.49998 · Cited by 28
Cunningham, G. R. (2013) · Endocrine Practice · doi:10.4158/ep13217.ra · Cited by 24
Self-citationNovo, S., Iacona, R., Bonomo, V., Evola, V., Corrado, E., Piazza, M. D., Novo, G., & Pavone, C. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.007 · Cited by 23
Grossmann, M., Anawalt, B. D., & Wu, F. C. W. (2014) · Clinical Endocrinology · doi:10.1111/cen.12594 · Cited by 23
Gynecomastia in subjects with sexual dysfunction
Maseroli, E., Rastrelli, G., Corona, G., Boddi, V., Amato, A. M. L., Mannucci, E., Forti, G., & Maggi, M. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0055-z · Cited by 23
Review: Anti-Oxidant and Anti-Aging Properties of Equol in Prostate Health (BPH)
Lephart, E. D. (2014) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2014.41001 · Cited by 22
Wu, F., Zitzmann, M., Heiselman, D., Donatucci, C., Knorr, J., Patel, A. B., & Kinchen, K. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.05.010 · Cited by 21
Cui, R., Kang, Y., Wang, L., Li, S., Ji, X., Yan, W., Zhang, G., Cui, H., & Shi, G. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00172 · Cited by 22
Sex steroids and cardiovascular disease
Yeap, B. B. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122357 · Cited by 20
Wang, H., Liu, L., Wang, J., Tong, Z., Yan, J., Zhang, T., Qin, Y., Jiang, T., She, J., & Shen, H. (2017) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.05.257 · Cited by 21
Brock, G. B., Heiselman, D., Knorr, J., Ni, X., & Kinchen, K. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.04.065 · Cited by 19
Testicular Failure and Male Infertility in the Monogenic Mulibrey Nanism Disorder
Karlberg, S., Toppari, J., Karlberg, N., Nurmio, M., Karikoski, R., Jalanko, H., & Lipsanen‐Nyman, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1493 · Cited by 19
Testosterone Treatment of Older Men—Why Are Controversies Created?
Swerdloff, R. S., & Wang, C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2538 · Cited by 19
Diagnosis and Treatment of Low Testosterone among Patients with End‐Stage Renal Disease
Bao, Y., & Johansen, K. L. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12318 · Cited by 18
Gore, A. C., Hall, J. E., & Hayes, F. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00037-5 · Cited by 19
Testosterone therapy in older men with late-onset hypogonadism: a counter-rationale
Basaria, S. (2013) · Endocrine Practice · doi:10.4158/ep13318.ra · Cited by 18
Krysiak, R. G., & Okopień, B. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12169 · Cited by 18
Sönmez, A., Haymana, C., Aydoğdu, A., Tapan, S., Başaran, Y., Meriç, C., Başköy, K., Dinç, M., Yazıcı, M., Taşlıpınar, A., et al. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0125 · Cited by 17
Fedotova, J., Soultanov, V., Nikitina, T. V., Roschin, V., Ordyan, N., & Hriţcu, L. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.08.065 · Cited by 17
Montagna, G., Balestra, S., D’Aurizio, F., Romanelli, F., Benagli, C., Tozzoli, R., Risch, L., Giovanella, L., & Imperiali, M. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-1201 · Cited by 17
Luigi, L. D., Sgrò, P., Aversa, A., Migliaccio, S., Bianchini, S., Botrè, F., Romanelli, F., & Lenzi, A. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02600.x · Cited by 16
Rosen, R. C., Wu, F. C. W., Behre, H. M., Roehrborn, C. G., Schröder, F. H., Siami, F. S., Martha, J. F., Finn, J. D., & de Araújo, A. B. (2013) · The Aging Male · doi:10.3109/13685538.2013.765403 · Cited by 14
Hormones and Cardiovascular Disease in Older Men
Yeap, B. B., & Flicker, L. A. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.12.004 · Cited by 15
Testosterone Deficiency Syndrome: An overview with emphasis on the diagnostic conundrum
Morales, Á. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.11.024 · Cited by 13
Angiotensin blockade attenuates diabetic nephropathy in hypogonadal adult male rats
Makary, S., Abdo, M., Hassan, W. A., & Tawfik, M. K. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0572 · Cited by 10
The Laboratory Diagnosis of Testosterone Deficiency
Mehta, A., & Paduch, D. A. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-179-0_2 · Cited by 11
Chasland, L. C., Knuiman, M. W., Divitini, M., Chan, Y. X., Handelsman, D. J., Naylor, L. H., GREEN, D. J., & Yeap, B. B. (2017) · Clinical Endocrinology · doi:10.1111/cen.13407 · Cited by 11
Trials of testosterone replacement reporting cardiovascular adverse events
Basaria, S. S., & Gagliano‐Jucá, T. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_28_17 · Cited by 10
Functional hypogonadism in middle-aged and older men: testosterone treatment or not?
Grossmann, M., & Jones, T. H. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0362 · Cited by 10
Lee, Y., Kang, Y.-R., Chang, Y., Kim, J., & Sung, M. (2025) · Obesity Reviews · doi:10.1111/obr.70026 · Cited by 13
Risks of Serious Injury with Testosterone Treatment
Yarnell, C. J., Thiruchelvam, D., & Redelmeier, D. A. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.07.037 · Cited by 10
Zhao, H., Gui, W., Liu, S., Zhao, F., Fan, W., Jing, F., & Sun, C. M. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1451481 · Cited by 8
Diagnosis and Treatment of Sexual Dysfunctions in Late-Onset Hypogonadism
Kim, J. W., & Moon, D. G. (2011) · Korean journal of urology · doi:10.4111/kju.2011.52.11.725 · Cited by 8
Issues Surrounding Testosterone Replacement Therapy
Schlich, C., & Romanelli, F. (2016) · Hospital Pharmacy · doi:10.1310/hpj5109-712 · Cited by 7
Episodic Transdermal Delivery of Testosterone
Malik, R., Venkatesh, K. S., Dwivedi, A. K., & Misra, A. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200558a · Cited by 5
Testosterone therapy and mortality in US veterans
Yeap, B. B. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2012.74 · Cited by 4
Morbidity and mortality in men: Role of androgens
Fallara, G., Pozzi, E., Corsini, C., Belladelli, F., Boeri, L., Capogrosso, P., Montorsi, F., & Salonia, A. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101662 · Cited by 5
Testosterone and sex in older men
Yeap, B. B. (2011) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2011.tb03206.x · Cited by 3
Testosterone deficiency in the ageing man: is the ‘male menopause’ an entity?
Thrower, S., & Ahmad, B. N. (2013) · Trends in Urology & Men s Health · doi:10.1002/tre.341 · Cited by 1
Age-Related Testosterone Decline: Whom Do We Treat and Why?
Ahmad, A. E., Bruha, M., & Welliver, C. (2016) · Current Sexual Health Reports · doi:10.1007/s11930-016-0074-1 · Cited by 2
Testosterone Hormone ; Clinical Indications, Dysregulation and Therapeutic methods
Al-Darawsha, T. Z. (2024) · Al-Ameed Journal for Medical Research and Health Sciences · doi:10.61631/3005-3188.1005 · Cited by 2
Testosterone and Cardiovascular Effects
Yeap, B. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_16 · Cited by 1
Hormone Replacement Therapy with Testosterone
Bassas, L., & Resmini, E. (2013) · Springer eBooks · doi:10.1007/978-3-642-37393-0_173-1 · Cited by 1
Raeisi‐Dehkordi, H., Amiri, M., Thorand, B., Peters, A., Rathmann, W., Zeller, T., Adamski, J., Franco, O. H., van der Schouw, Y. T., Muka, T., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.047531 · Cited by 1
MYTHS AND CONTROVERSIES IN HYPOGONADISM TREATMENT OF AGING MALES.
Ungureanu, M.-C., Costache, I. I., Preda, C., Mogoş, V., Vulpoi, C., & Leuștean, L. (2015) · The Medical-Surgical Journal · Cited by 1
Cunningham, R. L. (2012) · Journal of Steroids & Hormonal Science · doi:10.4172/2157-7536.s2-e001 · Cited by 1
Plasma Testosterone and Dihydrotestosterone as Markers of Heart Disease and Mortality in Older Men
Yeap, B. B. (2016) · Springer eBooks · doi:10.1007/978-94-007-7678-4_38 · Cited by 1
Testosterone and Cardiovascular Effects
Yeap, B. B. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_19 · Cited by 1
Treatment of Hypogonadism in Men
Mehta, A., Paduch, D. A., & Goldstein, M. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4405-2_5 · Cited by 1
Hormone Replacement Therapy with Testosterone and the Vascular System
Bassas, L., & Resmini, E. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_173
Mulibrey nanism: Characterization of hypogonadism, infertility and tumors
Karlberg, S. (2012) · Työväentutkimus Vuosikirja
Testosterone Replacement Therapy in Men: Effects on Fertility and Health
Chan, P. T. K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7187-5_4
Kowal, E., Pearson, G., Peacock, C. S., Jamieson, S. E., & Blackwell, J. M. (2013)
Testosterone Therapy: Optimizing Benefits and Minimizing Risks
Grossmann, M. (2015) · The Endocrine Society eBooks · doi:10.1210/mtp4.9781936704941.ch52
Low Testosterone: When to Treat?
Grossmann, M. (2014) · The Endocrine Society eBooks · doi:10.1210/mtp3.9781936704835.ch48
Metadata
- Authors
- Cunningham, G. R., & Toma, S. M.
- Affiliations
- Baylor St. Luke's Medical Center (US)
- Corresponding author
- Cunningham, Glenn R.
- ORCID
- Cunningham, Glenn R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-01-01
- Volume
- 96
- Issue
- 1
- Pages
- 38-52
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2129345748
- Cited by
- 111
- References
- 146
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 10 · 2015: 11 · 2014: 17 · 2013: 23 · 2012: 17
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- testosterone replacement therapy, male hypogonadism, androgen deficiency, risk-benefit assessment, prostate cancer risk, cardiovascular risk, hypothalamic-pituitary-gonadal axis, treatment monitoring, older men, chronic disease
- MeSH terms
- Androgens, Humans, Hypogonadism, Male, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review